Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists

Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: Orally bioavailable compounds Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: Identification of a lead and initial SAR studies 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB₂Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: A versatile architecture for CB2 selective ligands Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB₂ Cannabinoid Receptor Partial Agonists